India Glycols reported revenue of Rs795 crore during Q3FY22 against Rs712 crore for Q3FY21, up by 11% yoy. Revenue for the 9m period ended December 2021 stood at Rs2,226 crore against Rs1570 crore for the previous 9M period, up by 42.2% yoy.
EBIDTA plunged by 11.2% yoy at Rs62 crore for Q3FY22 against Rs69 crore in Q3FY21. For the 9 months ended December 2021, it grew by 3.2% yoy at Rs192 crore against Rs186 crore for the previous 9M period.
PAT for the quarter under review stood at Rs24 crore against Rs30 crore for the previous corresponding quarter, down by 19.5% yoy. While PAT for the 9M period widened significantly at Rs273 crore against Rs61 crore, registering a growth of 350% yoy.
Meanwhile, the stock was trading marginally higher at Rs824.80, up by 0.57% against its previous closing price of Rs820.15.
EBITDA and PAT Margin stood at 7.67% and 2.99% respectively for the current quarter. PAT margin improved significantly for the current 9M period to 11.71% from existing 2.84%.
Related Tags
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.